Evaluating the Efficacy of the Treatment with Benfotiamine and Alpha-lipoic Acid in Distal Symmetric Painful Diabetic Polyneuropathy

Abstract

Distal symmetric painful diabetic neuropathy is the most frequent clinical form of diabetic neuropathy. The condition appears as a result of alteration of the structure and function of nervous fibres as a consequence of hyperglycaemia. Hyperglycaemia determines the metabolism of glucose on alterative pathways and generates increased oxidative stress, mechanisms that cause an accelerated apoptosis of the neurons and a high intensity of lipid peroxidation. Pathogenic treatment of diabetic neuropathy includes limited options, two of them are: Benfotiamine (inhibits the metabolism of glucose on hexosamine pathway, reducing the formation of advanced glycosylation end products) and alpha-lipoic acid (has a scavenger effect on free radical species). The study included 120 patients with distal symmetric painful diabetic neuropathy randomized in 3 treatment groups. We evaluated the effect of oral administration for 8 weeks of Benfotiamine in a dosage of 300mg/day in monotherapy, of alpha-lipoic acid in a dosage of 600 mg/day in monotherapy, respectively of both -in combined therapy - on the parameters that are used to determine the severity of distal symmetric painful diabetic neuropathy: Diabetic Neuropathy Symptoms score, Neuropathy Disability Score and the intensity of lower limb pain on the visual analogue pain scale. All the three therapies were effective with a statistically significant improvement of these parameters, but the combined therapy with alpha-lipoic acid and Benfotiamine was superior to the monotherapy with alpha-lipoic acid or Benfotiamine.

Acute Coronary Syndromes in Chronic Kidney Disease: Clinical and Therapeutic Characteristics

“…CAD has several particularities in CKD consisting in high incidence, rapid progression, elevated prevalence of multi-vessel disease, and presence of vascular calcifications that interfere with proper stent expansion. Results regarding the high incidence of three-vessel CAD and LMCA in CKD patients were similar to other findings of similar studies, but they did not reach the statistically significant number due to the low number of patients and a single experimental centre [34,[37][38][39]. Revascularization with PCI or CABG is challenging.…”

Risk factors for adiposity in the urban population and influence on the prevalence of overweight and obesity

“…Individuals with fast-food consumption also consume a high quantity of sweetened beverages (11). Nutrition interventions are effective measures to improve diet quality (12). One meta-analysis evaluating 14 studies carried out on college students demonstrated that nutrition education provided as lectures, web education or giving informative supplements, significantly improves nutrition knowledge and dietary practices (13).…”

Influence of inflammation and adipocyte biochemical markers on the components of metabolic syndrome

“…Lifestyle changes have triggered the obesity epidemic; obesity is the main cause for metabolic syndrome because obesity generates insulin resistance and insulin resistance is associated with all the components of metabolic syndrome (7). Adipocytes are metabolically active cells generating different metabolites called adipokines that act at different levels, some of them increasing the risk of diabetes and cardiovascular disease such as C-reactive protein (CRP), tumour necrosis factor α (TNFα) and interleukin-6 (IL-6), plasminogen activator inhibitor-1 (PAI-1), some of them decreasing, at least theoretically, the risk of diabetes and atherosclerosis such as adiponectin (8).…”